See Tai Sandi (CIK 0002009350)

Latest company ownership

LXEO - Lexeo Therapeutics, Inc.
Role: Chief Development Officer
Shares held
65,476
Last filed at
Nov 20, 2025
Confidence Score
68.4
2025Q4
Confidence Score History
2025Q1 2025Q4

Recent buy/sell transactions

Exec date Filing date Company Role Signal Confidence Shares % of shares Under plan? Amount (USD)
Nov 18, 2025 Nov 20, 2025 Lexeo Therapeutics, Inc. Chief Development Officer Sell 37.5 -386 -0.59% ✗ $3.6K
Oct 15, 2025 Oct 17, 2025 Lexeo Therapeutics, Inc. Chief Development Officer Sell 91.3 +7,002 11.90% ✗ $34.8K
Aug 18, 2025 Aug 20, 2025 Lexeo Therapeutics, Inc. Chief Development Officer Sell 37.5 -382 -0.64% ✗ $1.8K
May 16, 2025 May 20, 2025 Lexeo Therapeutics, Inc. Chief Development Officer Sell 37.5 -367 -0.62% ✗ $1K
Feb 19, 2025 Feb 21, 2025 Lexeo Therapeutics, Inc. Chief Development Officer Sell 27.5 -1,486 -2.68% ✗ $6.6K